Michael N Dudley

This inventor holds 36 USPTO granted patents and 14 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Rempex Pharmaceuticals, Inc., Melinta Subsidiary Corp., Horizon Orphan LLC. Active years: 2010-2026.

USPTO Granted Patents = 36 (Patent Applications = 14)

% Patents Active = 97.2

CIPO Patents = 6

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 4.9

ph-index = 10

Forward Citations = 285(Granted Patents)

Company Filing History:

11 out of 27

Rempex Pharmaceuticals, Inc.

patents

9 out of 15

Melinta Subsidiary Corp.

Mpex Pharmaceuticals, Inc.

patents

5. 1 out of 12

Raptor Pharmaceuticals Inc.

patents

6. 1 out of 834,307

Other

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Cyclic Boronic Acid

Pharmaceutical Compositions

Aerosolized Fluoroquinolones

Tetracycline

Levofloxacin

Bacterial Infections

Therapeutic Uses

Lung Inflammation

Cystic Fibrosis

Improved Pharmacokinetics

Topical Use

Aerosol Fluoroquinolone

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12533342 - Methods of treating bacterial infections (2026-01-27),

2. 12478606 - Methods of treating bacterial infections (2025-11-25),

3. 12171772 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2024-12-24),

4. 12161656 - Tetracycline compositions (2024-12-10),

5. 11944634 - Tetracycline compositions (2024-04-02),

6. 11684629 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2023-06-27),

7. 11376237 - Methods of treating bacterial infections (2022-07-05),

8. 11090319 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2021-08-17),

9. 11020481 - Topical use of levofloxacin for reducing lung inflammation (2021-06-01),

10. 11007206 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2021-05-18),

11. 10987357 - Aerosolized fluoroquinolones and uses thereof (2021-04-27),

12. 10792289 - Use of aerosolized levofloxacin for treating cystic fibrosis (2020-10-06),

13. 10722519 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2020-07-28),

14. 10639318 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2020-05-05),

15. 10561675 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2020-02-18),

Title: The Innovative Journey of Michael N Dudley

Introduction: Michael N Dudley is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: Michael N Dudley's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable materials, and advanced healthcare solutions, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Michael N Dudley has established himself as a leading figure in the innovation landscape, with numerous successful inventions that have had a significant impact on industries worldwide.

Collaborations: Throughout his career, Michael N Dudley has collaborated with top research institutions, leading companies, and innovative startups to bring his ideas to life and drive positive change through his inventions.

Conclusion: Michael N Dudley's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, continues to inspire the next generation of inventors and solidify his legacy as a true pioneer in the world of inventions.